IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Third Rock Ventures, LLC

Q3 2014 Holdings

Filed 2014-10-22 | 6 holdings | $189.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals, Inc.(AGIO)COM00847X104$188.4M3,070,09099.6%
Sage Therapeutics, Inc.(SG7)COM78667J108$368.0K11,681,0080.2%
Zafgen Inc.COM98885E103$110.1K5,602,0450.1%
Foundation Medicine, Inc.COM350465100$93.4K4,927,2340.0%
Eleven Biotherapeutics, Inc.COM286221106$53.9K4,841,5910.0%
bluebird bio, Inc.COM09609G100$43.6K1,215,0540.0%